Pharmacyclics, Inc. today announced that it has been awarded BayBio's 2014 Pantheon DiNA Award for Outstanding Company for its rapid development and commercialization of IMBRUVICA (ibrutinib). The award was presented at BayBio's 11th Annual Pantheon DiNA Awards ceremony in San Francisco.
from The Medical News http://ift.tt/1uBAQEE
from The Medical News http://ift.tt/1uBAQEE
No comments:
Post a Comment